News

Forest Labs and Nycomed claimed that if approved, roflumilast, a once-a-day oral tablet, will be the first in a new class of treatment for COPD. Roflumilast is not

The patents are the most recent of 13 international and US patents to issue to the University of Michigan for breast cancer diagnostic and therapeutic uses of Mammastatin.

As per the terms of the settlement agreement, AstraZeneca has granted Teva a license to enter the US market with its generic version of oral Budesonide on February

Reportedly, the eight-month research program is coupled with an exclusive license to genOway for the rodent transgenic business. The research program aims at establishing germline transmission in rats

IOLCP expects a turnover of about INR600m per annum from this initiative to diversify into new generic products and is expected to raise the required capital from international

Bayer Schering Pharma said that the model introduces a newly formed ‘Science Hub’ for innovation sourcing in the US creating collaborations with academic research scientists and small biotech

Mr McCoy is currently working as a president of McCoy Enterprises, a company responsible for development of the patented buccal mucosa oral drug delivery system for which Spring

Asthmatx chose OmniComm’s TrialMaster EDC and Trial Management solution in 2005 to help fill its data collection, management and reporting needs. Stephen Johnson, chief operating officer of OmniComm

Mr Horgan began working in the drug development sector in 1997 and moved to the US in 2000. He began working with Firecrest Clinical in 2009 to establish